2011
DOI: 10.1172/jci42846
|View full text |Cite
|
Sign up to set email alerts
|

Combined deletion of Fxr and Shp in mice induces Cyp17a1 and results in juvenile onset cholestasis

Abstract: Bile acid homeostasis is tightly regulated via a feedback loop operated by the nuclear receptors farnesoid X receptor (FXR) and small heterodimer partner (SHP). Contrary to current models, which place FXR upstream of SHP in a linear regulatory pathway, here we show that the phenotypic consequences in mice of the combined loss of both receptors are much more severe than the relatively modest impact of the loss of either Fxr or Shp alone. Fxr -/-Shp -/-mice exhibited cholestasis and liver injury as early as 3 we… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

11
125
5

Year Published

2012
2012
2017
2017

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 108 publications
(144 citation statements)
references
References 75 publications
11
125
5
Order By: Relevance
“…Also, the importance of HDAC7 in the feedback regulation of CYP7A1 has been reported, revealing HDAC7 as a potential target for treating hypercholesterolemia (37). Although BAs have beneficial roles in removing excess cholesterol and counteracting obesity by reducing TG levels, abnormally elevated hepatic BA levels are associated with hepatobiliary disease, like cholestasis, as recently demonstrated in SHP-KO (38) and SHP/FXR-KO mouse studies (39). In this work, we have shown the crucial role of phosphorylation of SHP at a single site by PKC in BA signal-induced epigenomic regulation of liver metabolic genes.…”
Section: Discussionmentioning
confidence: 90%
“…Also, the importance of HDAC7 in the feedback regulation of CYP7A1 has been reported, revealing HDAC7 as a potential target for treating hypercholesterolemia (37). Although BAs have beneficial roles in removing excess cholesterol and counteracting obesity by reducing TG levels, abnormally elevated hepatic BA levels are associated with hepatobiliary disease, like cholestasis, as recently demonstrated in SHP-KO (38) and SHP/FXR-KO mouse studies (39). In this work, we have shown the crucial role of phosphorylation of SHP at a single site by PKC in BA signal-induced epigenomic regulation of liver metabolic genes.…”
Section: Discussionmentioning
confidence: 90%
“…Whole-body FXR-deficient mice exhibited a significant accumulation of hepatic and plasma triglyceride levels as well as of VLDL, LDL, and HDL (46,47). Other studies revealed that the hepatic FXR/SHP pathway inhibits SREBP1C and microsomal triglyceride transfer proteinmediated (MTP-mediated) hepatic lipogenesis (48)(49)(50). However, activation of FXR with the synthetic agonist GW4064 increased HFD-induced lipid accumulation in the liver, partially due to a significant reduction in BA pool size and energy expenditure (51).…”
Section: Discussionmentioning
confidence: 99%
“…In the subsequent study, examining the expression of FXR signaling-related proteins in hepatocytes, the mechanisms underlying the effects of bile acid and FXR on lipid metabolism and liver regeneration were investigated. Activated FXR stimulated expression of SHP, which integrated with the liver receptor homolog and inhibited transcription of CYP7A1 (31,32). Bile acid is known to be a regulator of cysteine sulfinic acid decarboxylase via mechanisms shared in part with CYP7A1, and may affect cholesterol via CYP7A1 through the downregulation of the hepatic FXR/SHP pathway (33,34).…”
Section: Discussionmentioning
confidence: 99%